Salvage chemotherapy for adults with relapsed or refractory lymphoma in Malawi
Abstract Background Lymphoma is highly associated with HIV in sub-Saharan Africa (SSA), which contributes to worse outcomes relative to resource-rich settings, and frequent failure of first-line chemotherapy. However, there are no second-line treatment descriptions for adults with relapsed or refrac...
Main Authors: | Bongani Kaimila, Toon van der Gronde, Christopher Stanley, Edwards Kasonkanji, Maria Chikasema, Blessings Tewete, Paula Fox, Satish Gopal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Infectious Agents and Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13027-017-0156-3 |
Similar Items
-
Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort studyResearch in context
by: Marriam Mponda, et al.
Published: (2024-03-01) -
Modified EPOCH for high‐risk non‐Hodgkin lymphoma in sub‐Saharan Africa
by: Takondwa Zuze, et al.
Published: (2020-01-01) -
Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases
by: Tamiwe Tomoka, et al.
Published: (2017-09-01) -
GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
by: Mani Ramzi, et al.
Published: (2015-03-01) -
Plasmablastic lymphoma in Malawi
by: Takondwa Zuze, et al.
Published: (2018-06-01)